January 9, 2025 - 19:58

Attorneys Heidi Urness and Rudy Cerone have shared insights into the opportunities available within the realm of distressed marijuana businesses. As the cannabis industry continues to evolve, many companies face significant challenges, creating a landscape ripe for investment and strategic partnerships.
Urness emphasizes the importance of due diligence when evaluating these businesses. She notes that understanding the underlying reasons for distress—be it financial mismanagement, regulatory hurdles, or market competition—is crucial in determining whether a business can be turned around.
Cerone adds that potential investors should look for signs of resilience and adaptability within a company. Factors such as a strong brand presence, a loyal customer base, and innovative product offerings can indicate a business's potential for recovery.
In a market that remains volatile, Urness and Cerone advocate for a cautious yet optimistic approach, encouraging stakeholders to recognize the unique opportunities that distressed marijuana businesses can offer.
March 18, 2026 - 11:16
Five Key Takeaways from a Weekend Coding Class for Non-Technical MindsThe idea of building an app in a single weekend seemed like a distant fantasy, something reserved for seasoned developers. Yet, a recent weekend `vibe coding` class made that a tangible reality,...
March 17, 2026 - 21:39
Orange Bank & Trust Company Celebrates Women’s Leadership at Annual Bronx Women in Business EventOrange Bank & Trust Company recently hosted its second annual Bronx Women in Business event, a vibrant celebration of female entrepreneurship and leadership within the borough. The gathering...
March 17, 2026 - 04:07
Autonomous businesses – from Waymo to mattress stores – are on the riseThe familiar chime of a door opening to reveal an empty room is becoming an increasingly common retail experience. From driverless taxis to fully automated mattress showrooms, autonomous businesses...
March 16, 2026 - 18:22
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsCue Biopharma has released its financial and operational results for the fourth quarter and full year ending 2025, detailing a period marked by strategic pipeline advancement and key corporate...